Navigation Links
Super-sized cassava plants may help fight hunger in Africa

In a recent study, genetically modified cassava plants produced roots that were more than two-and-a-half times the size of normal cassava roots.

The findings could help ease hunger in many countries where people rely heavily on the cassava plant (Manihot esculenta) as a primary food source, said Richard Sayre, the study's lead author and a professor of plant cellular and molecular biology at Ohio State University.

The researchers used a gene from the bacterium E. coli to genetically modify cassava plants. The plants, which were grown in a greenhouse, produced roots that were an average of 2.6 times larger than those produced by regular cassava plants.

"Not only did these plants produce larger roots, but the whole plant was bigger and had more leaves," Sayre said. Both the roots and leaves of the cassava plant are edible.

Cassava is the primary food source for more than 250 million Africans ?about 40 percent of the continent's population. And the plant's starchy tuberous root is a substantial portion of the diet of nearly 600 million people worldwide.

Sayre said he hopes to offer these plants to countries where cassava is an important crop.

The current study appears in the online early issue of the Plant Biotechnology Journal. Sayre collaborated with Ohio State colleague Uzoma Ihemere and scientists from BASF Plant Science in Research Triangle Park, N.C., and BARC-West in Beltsville, Md., who formerly worked on this project in his laboratory.

Sayre said that cassava produces sugar more efficiently than any other cultivated plant.

"We wanted to find a way to help the plant redirect that excess sugar and use it to make starch," Sayre said.

The researchers used a variety of cassava native to Colombia (cassava was brought to Africa from South America by the Portuguese in the 1500s.) They inserted into three cassava plants an E. coli gene that controls starch production. A non-modified fourth plant ser
'"/>

Source:Ohio State University


Page: 1 2

Related biology news :

1. Research team receives $7.5 million to study cassava
2. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
3. Antibodies from plants protect against anthrax
4. New RNA polymerase discovered in plants
5. Transgenic plants remove more selenium from polluted soil than wild plants, new tests show
6. Scientists discover how plants disarm the toxic effects of excessive sunlight
7. Defenseless plants arm themselves with metals
8. At long last, scientists figure out how plants grow
9. Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes
10. Engineers improve plastics potential for use in implants by linking it to biological material
11. Innovative coating could give medical implants a longer life
Post Your Comments:
(Date:2/9/2010)... majority owned subsidiary of Avisio, Inc. acquired an ... , The technology is based on an ... e.g. mosquitos and black flies, utilize their olfactory ... animals and humans. CO2, which is a major ... insect to its prey. , Developed by ...
(Date:2/8/2010)... Mediterranean diet may help people avoid the small areas ... thinking and memory, according to a study released today ... Neurology,s 62nd Annual Meeting in Toronto April 10 to ... people who ate a Mediterranean-like diet were less likely ... tissue linked to thinking problems. , The Mediterranean ...
(Date:2/8/2010)... With the recent election of Senator ... in the loss of the Democratic supermajority, the urgency ... universal coverage for the majority of uninsured Americans has ...  President Obama recently noted the country is closer than ... for many a long sought after social reform, and ...
Breaking Biology News(10 mins):Mediterranean diet may lower risk of brain damage that causes thinking problems 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 3S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 4S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 5S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 6S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 7S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 8S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 9Census Bureau Releases Comprehensive Health Insurance Coverage Estimates by County 53506 1Census Bureau Releases Comprehensive Health Insurance Coverage Estimates by County 53506 2Hard to Treat Diseases Inc 28HTDS 29 Experiments with Hyperbaric Oxygenation 28HBO 29 Traumatic Brain Injury 53504 1Hard to Treat Diseases Inc 28HTDS 29 Experiments with Hyperbaric Oxygenation 28HBO 29 Traumatic Brain Injury 53504 2Hard to Treat Diseases Inc 28HTDS 29 Experiments with Hyperbaric Oxygenation 28HBO 29 Traumatic Brain Injury 53504 3Hard to Treat Diseases Inc 28HTDS 29 Experiments with Hyperbaric Oxygenation 28HBO 29 Traumatic Brain Injury 53504 4Exercise Is Healthy for Mom and Child During Pregnancy 53502 1Exercise Is Healthy for Mom and Child During Pregnancy 53502 2Exercise Is Healthy for Mom and Child During Pregnancy 53502 3
... reported findings that offer a surprising new twist to ... select the flowers from which they collect nectar. When ... flowers entirely alone but instead copy the choices of ... their behavior when dealing with flowers of unfamiliar plant ...
... paths some 5 million to 6 million years ago, we ... and acquired a knack for abstract thought while our next ... to construct tree-bound nests high above the forest floor. We ... sequence level, yet scientists predict that both species should harbor ...
... River varies in time, what causes those variations, and ... deforestation is a focus of study for scientists at ... in the last several decades have led to significant ... eastern and southern portion of the basin. By using ...
Other Biology News:Can our genes tell the story of our divergence? 2Assessing the Amazon River's sensitivity to deforestation 2
(Date:2/9/2010)... endpoint Clinical ( www.endpointclinical.com ), a ... (IWR) systems, announced today that PULSE, a fully ... deploy clinical trial Integrated Response Technology (IRT) systems, ... clinical trials. This time and cost savings stems ... developers do not have to spend valuable time ...
(Date:2/9/2010)... A leading clinical research center in ... study an investigational drug designed as a possible treatment ... affects between 45 and 90 percent of women of ... not life threatening, dysmenorrhea can be debilitating and psychologically ... absenteeism from work and school. ,, Current therapies for ...
(Date:2/9/2010)... and AMSTERDAM , February 9 ... cancer diagnostics, announced today that,it has received the ... State ,Department of Health. The New York ... samples of MammaPrint, its FDA-cleared breast cancer recurrence,test. ... permit, Agendia has now obtained all major U.S. ...
(Date:2/9/2010)... Belgium , February 9 ... the Potential of Microplasmin to Improve the Treatment,of ... ,, ThromboGenics NV (Euronext ... and development of innovative treatments for eye,disease, vascular ... Phase II trial results, evaluating the product,s efficacy ...
Breaking Biology Technology:endpoint Saves Money and Time for Medical Research Teams Through PULSE 2endpoint Saves Money and Time for Medical Research Teams Through PULSE 3Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps 2Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 3ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 4
... Nov. 26 Evalve, Inc., the leader in,the ... cardiac valves,announced today that the first three patients ... the University of Hull, Castle Hill Hospital,in the ... commercially,available medical device which provides a non-surgical mitral ...
... an update on internal policy and clinical, ... Symbol: RVX , , CALGARY, ... that the previously announced internal blackout trading restriction of April ... regional and global partnerships are actively ongoing and should the ...
... Nov. 26 Thomas K. Equels, President and Managing,Director ... the board of directors,for Hemispherx BioPharma, Inc. (Amex: ... manufacture and clinical development,of new drug entities for the ... Equels, legal practice is devoted ...
Other Biology Technology:First United Kingdom Patients Treated With Percutaneous MitraClip(R) System 2First United Kingdom Patients Treated With Percutaneous MitraClip(R) System 3Resverlogix Board of Directors Update 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 3
... II xi 2-D system runs both gel dimensions in ... gels can be separated in a single run using ... core in much the same manner as the slab ... second-dimension slab gels may be cast in the casting ...
... Experion StdSens analysis kit for 25 chips ... perform standard-sensitivity RNA analysis (at nanogram levels) ... kit includes 25 RNA StdSens microfluidic chips, ... x 20 microliters RNA StdSens stain, 2 ...
... Rotator, variable speed, timer, SB3, Fully adjustable ... of tube holders to hold a number ... SB3 is ideal for aerating cultures, keeping ... mixing applications., The rotator can be used ...
...
Biology Products: